PDS Biotechnology Corp (PDSB)
3.825
+0.10
(+2.82%)
USD |
NASDAQ |
May 03, 16:00
3.825
0.00 (0.00%)
After-Hours: 19:29
PDS Biotechnology Price to Book Value: 5.369 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 5.222 |
| May 01, 2024 | 5.067 |
| April 30, 2024 | 4.702 |
| April 29, 2024 | 4.758 |
| April 26, 2024 | 4.59 |
| April 25, 2024 | 4.576 |
| April 24, 2024 | 4.562 |
| April 23, 2024 | 4.492 |
| April 22, 2024 | 4.197 |
| April 19, 2024 | 3.713 |
| April 18, 2024 | 4.071 |
| April 17, 2024 | 3.818 |
| April 16, 2024 | 3.930 |
| April 15, 2024 | 3.958 |
| April 12, 2024 | 4.478 |
| April 11, 2024 | 4.730 |
| April 10, 2024 | 4.422 |
| April 09, 2024 | 4.59 |
| April 08, 2024 | 4.646 |
| April 05, 2024 | 4.534 |
| April 04, 2024 | 4.618 |
| April 03, 2024 | 5.166 |
| April 02, 2024 | 5.222 |
| April 01, 2024 | 5.643 |
| March 28, 2024 | 5.558 |
| Date | Value |
|---|---|
| March 27, 2024 | 5.404 |
| March 26, 2024 | 6.288 |
| March 25, 2024 | 6.639 |
| March 22, 2024 | 6.485 |
| March 21, 2024 | 6.850 |
| March 20, 2024 | 6.092 |
| March 19, 2024 | 5.940 |
| March 18, 2024 | 6.022 |
| March 15, 2024 | 6.206 |
| March 14, 2024 | 6.060 |
| March 13, 2024 | 6.016 |
| March 12, 2024 | 5.858 |
| March 11, 2024 | 6.282 |
| March 08, 2024 | 6.915 |
| March 07, 2024 | 7.371 |
| March 06, 2024 | 7.650 |
| March 05, 2024 | 7.346 |
| March 04, 2024 | 7.814 |
| March 01, 2024 | 8.346 |
| February 29, 2024 | 8.346 |
| February 28, 2024 | 7.434 |
| February 27, 2024 | 7.726 |
| February 26, 2024 | 7.016 |
| February 23, 2024 | 6.864 |
| February 22, 2024 | 6.776 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5012
Minimum
Apr 02 2020
13.63
Maximum
Jun 28 2021
3.610
Average
3.275
Median
Price to Book Value Benchmarks
| Syros Pharmaceuticals Inc | 8.145 |
| PAVmed Inc | -- |
| Altimmune Inc | 2.670 |
| Regeneron Pharmaceuticals Inc | 4.047 |
| iBio Inc | 0.7426 |
Price to Book Value Related Metrics
| Price | 3.825 |
| Earnings Yield | -36.34% |
| Market Cap | 140.30M |